AlphaYouCORT: Vieira Roberto Wandenkolk discloses securities transactions
By AlphaYouPublished Form 4
Vieira Roberto Wandenkolk
Reporting filer
Vieira Roberto Wandenkolk reported Exercise or conversion in CORCEPT THERAPEUTICS INC: 8333 units of Common Stock, dated 2026-10-02. The full Form 4 contains 5 transaction entries.
- Disclosed
- Oct 5, 2026
Reported details
5 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Vieira Roberto Wandenkolk | 2026-10-02 | M | Exercise or conversion | 8333 | 21.63 | 12,279 | 3 days | Filed terms
|
| Common Stock | Vieira Roberto Wandenkolk | 2026-10-02 | S | Sale | 1100 | 114.5205 | 11,179 | 3 days | Filed terms
|
| Common Stock | Vieira Roberto Wandenkolk | 2026-10-02 | S | Sale | 2086 | 115.7298 | 9,093 | 3 days | Filed terms
|
| Common Stock | Vieira Roberto Wandenkolk | 2026-10-02 | S | Sale | 5147 | 116.585 | 3,946 | 3 days | Filed terms
|
| Stock option (right to buy) (derivative) | Vieira Roberto Wandenkolk | 2026-10-02 | M | Exercise or conversion | 8333 | 0.00 | 133,334 | 3 days | Filed terms
|
Common Stock
- Owner
- Vieira Roberto Wandenkolk
- Date
- 2026-10-02
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 8333
- Price
- 21.63
- Following holdings
- 12,279
- Reporting delay
- 3 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-02
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: false
- transaction Shares: 8333
- transaction Price Per Share: 21.63
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 12279
- id: F1
- direct Or Indirect Ownership: D
Common Stock
- Owner
- Vieira Roberto Wandenkolk
- Date
- 2026-10-02
- Code
- S
- Action
- Sale
- Quantity
- 1100
- Price
- 114.5205
- Following holdings
- 11,179
- Reporting delay
- 3 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-02
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: false
- id: F2
- transaction Shares: 1100
- transaction Price Per Share: 114.5205
- id: F3
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 11179
- id: F1
- direct Or Indirect Ownership: D
Common Stock
- Owner
- Vieira Roberto Wandenkolk
- Date
- 2026-10-02
- Code
- S
- Action
- Sale
- Quantity
- 2086
- Price
- 115.7298
- Following holdings
- 9,093
- Reporting delay
- 3 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-02
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: false
- id: F2
- transaction Shares: 2086
- transaction Price Per Share: 115.7298
- id: F4
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 9093
- id: F1
- direct Or Indirect Ownership: D
Common Stock
- Owner
- Vieira Roberto Wandenkolk
- Date
- 2026-10-02
- Code
- S
- Action
- Sale
- Quantity
- 5147
- Price
- 116.585
- Following holdings
- 3,946
- Reporting delay
- 3 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-02
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: false
- id: F2
- transaction Shares: 5147
- transaction Price Per Share: 116.585
- id: F5
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 3946
- id: F1
- direct Or Indirect Ownership: D
Stock option (right to buy) (derivative)
- Owner
- Vieira Roberto Wandenkolk
- Date
- 2026-10-02
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 8333
- Price
- 0.00
- Following holdings
- 133,334
- Reporting delay
- 3 days
- Filed terms and references
Filed terms
- security Title: Stock option (right to buy)
- conversion Or Exercise Price: 21.63
- transaction Date: 2026-10-02
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: false
- transaction Shares: 8333
- transaction Price Per Share: 0.00
- transaction Acquired Disposed Code: D
- id: F6
- expiration Date: 2034-02-01
- underlying Security Title: Common Stock
- underlying Security Shares: 8333
- shares Owned Following Transaction: 133334
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Vieira Roberto Wandenkolk: President, Oncology.
- The filing reports a Rule 10b5-1 trading plan.
- F1: Includes 179 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 396 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026, 634 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026 and 138 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.
- F2: This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on June 17, 2026, prior to the Reporting Person being appointed an officer of the Issuer, which was in effect at the time of this transaction.
- F3: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $114.03 to $114.90 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- F4: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $115.16 to $116.04 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- F5: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $116.24 to $117.22 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- F6: Shares subject to the stock option vested and became exercisable with respect to 25% of the shares underlying the option on January 29, 2025 with the remaining shares vesting and becoming exercisable ratably on a monthly basis over a period of 36 consecutive months thereafter until fully vested and exercisable on January 29, 2028, subject to the Reporting Person's continued service.
Original sources
Prepared automatically from public filing data. Report a correction.